Nureca Ltd Faces Intense Selling Pressure Amid Continued Price Declines
Nureca Ltd is experiencing notable selling pressure, continuing a trend of losses in the medical equipment sector. The stock has significantly underperformed compared to the Sensex over various timeframes, reflecting ongoing challenges for the microcap company amidst a generally positive market environment for its sector.
Nureca Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, highlighting a challenging environment for the microcap company in the medical equipment sector. In terms of performance, Nureca Ltd has underperformed relative to the Sensex, particularly over the longer term. Over the past three months, the stock has declined by 26.47%, while the Sensex has gained 4.99%. Year-to-date, Nureca is down 10.62%, contrasting sharply with the Sensex's 2.37% increase. The stock's performance over the past year also reflects a decline of 14.07%, compared to the Sensex's rise of 8.31%.
Today, Nureca opened at 252 and has remained at this price, underperforming its sector by 1.64%. While the stock is trading above its 5-day, 20-day, and 50-day moving averages, it remains below its 100-day and 200-day moving averages. The broader medical equipment sector has seen a gain of 2.48%, further emphasizing Nureca's struggles in the current market landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
